Baird Financial Group Inc. grew its position in shares of Waters Co. (NYSE:WAT – Get Rating) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 29,221 shares of the medical instruments supplier’s stock after acquiring an additional 3,446 shares during the quarter. Baird Financial Group Inc.’s holdings in Waters were worth $10,011,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently bought and sold shares of WAT. Wellington Management Group LLP raised its stake in shares of Waters by 79.6% during the 1st quarter. Wellington Management Group LLP now owns 1,504,592 shares of the medical instruments supplier’s stock worth $467,011,000 after purchasing an additional 666,851 shares during the period. Balyasny Asset Management LLC bought a new stake in shares of Waters during the 3rd quarter worth $44,489,000. Allspring Global Investments Holdings LLC raised its stake in shares of Waters by 1,891.1% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 173,030 shares of the medical instruments supplier’s stock worth $59,277,000 after purchasing an additional 164,340 shares during the period. Robeco Schweiz AG raised its stake in shares of Waters by 301.4% during the 4th quarter. Robeco Schweiz AG now owns 135,513 shares of the medical instruments supplier’s stock worth $46,424,000 after purchasing an additional 101,757 shares during the period. Finally, Thrivent Financial for Lutherans raised its stake in shares of Waters by 1,012.0% during the 3rd quarter. Thrivent Financial for Lutherans now owns 107,493 shares of the medical instruments supplier’s stock worth $28,972,000 after purchasing an additional 97,826 shares during the period. 88.58% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the company. Citigroup lifted their target price on Waters from $325.00 to $340.00 and gave the stock a “neutral” rating in a research note on Thursday, February 16th. Stifel Nicolaus lowered their target price on Waters from $345.00 to $315.00 in a research note on Wednesday, May 10th. Bank of America lowered their target price on Waters from $350.00 to $315.00 in a research note on Wednesday, May 10th. StockNews.com cut Waters from a “buy” rating to a “hold” rating in a research note on Friday, May 12th. Finally, Barclays lowered their price objective on Waters from $350.00 to $325.00 in a research note on Wednesday, May 10th. Eight investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $335.27.
Waters Trading Down 0.3 %
Waters (NYSE:WAT – Get Rating) last announced its quarterly earnings results on Tuesday, May 9th. The medical instruments supplier reported $2.49 earnings per share for the quarter, missing the consensus estimate of $2.60 by ($0.11). Waters had a net margin of 23.22% and a return on equity of 149.31%. The company had revenue of $684.67 million for the quarter, compared to the consensus estimate of $697.86 million. During the same quarter in the prior year, the company earned $2.80 earnings per share. The company’s quarterly revenue was down .9% on a year-over-year basis. On average, equities analysts forecast that Waters Co. will post 12.58 EPS for the current fiscal year.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
- Get a free copy of the StockNews.com research report on Waters (WAT)
- FuelCell Is Back To Realistic Valuation
- MarketBeat Week in Review – 6/4 – 6/9
- Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition
- Tax Software Specialist Vertex In Buy Zone After Base Breakout
- What is a Mutual Fund? How Does it Work?
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT – Get Rating).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.
